GHRS
GH Research PLC
NASDAQ · Healthcare · Biotechnology · IE
$28.23
+1.11%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+30.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Moore Duncan · director | A-Award | 2,202 | $0.03 |
| Aug 13, 2026 | Hanley Dermot John · director | A-Award | 2,202 | $0.03 |
| Aug 13, 2026 | Forer Michael · director | A-Award | 2,202 | $0.03 |
| Aug 13, 2026 | Forer Michael · director | A-Award | 100,000 | $0.03 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 21Reduced 15Sold out 54
| Filer | Action | Shares | Filed |
|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | Increased | 10,763,288 | May 4, 2026 |
| BVF INC/IL | Reduced | 8,650,158 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 7,676,697 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 5,933,815 | May 15, 2026 |
| FMR LLC | Unchanged | 5,136,045 | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 1,800,000 | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | New Position | 1,800,000 | Mar 16, 2026 |
| TORONTO DOMINION BANK | New Position | 1,397,873 | May 15, 2026 |
| TROLUCE CAPITAL ADVISORS LLC | Increased | 990,472 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 937,898 | May 15, 2026 |
| JEFFERIES FINANCIAL GROUP INC. | Unchanged | 712,300 | May 8, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Unchanged | 572,665 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 455,618 | May 13, 2026 |
| UBS GROUP AG | Increased | 412,416 | May 5, 2026 |
| Squadron Capital Management LLC | Increased | 325,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 13, 2026